Botanicals as a zinc oxide alternative to protect intestinal cells from an Escherichia coli F4 infection in vitro by modulation of enterocyte inflammatory response and bacterial virulence
Bonetti et al. (2023). Front. Vet. Sci., 10, 1141561-1147574
Species
Swine
Our microencapsulation technology empowered the delivery and the slow-release of active ingredients to the intestine of swine, bypassing the gastric environment. Our scientific research demonstrated that it is possible to maximize performance by lowering the concentration of the active compounds.
Zincoret®S
Zincoret®S is a source of zinc oxide, microencapsulated in a lipid matrix, to allow a higher availability at the intestinal level and a lower inclusion in the feed.
BENEFITS
- Improvement of growth performance at weaning
- Reduction of intestinal inflammation
- Enhancement of intestinal structure and health
FEATURES
- Delivery of active zinc oxide at the intestinal level
- Sustainable alternative to high-dose zinc oxide
- Reduced environmental impact
MICROENCAPSULATION TECHNOLOGY
- The zinc oxide in Zincoret®S is microencapsulated in a lipid matrix, to allow its transit through the stomach without being affected by the action of hydrochloric acid.
- Therefore, Zincoret®S delivers unaltered zinc oxide in the intestine of pigs, being already effective at low doses. Microencapsulation technology allows zinc oxide slow-release throughout the intestinal tract.
